🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Causeway Therapeutics is grateful to Innovate UK for the award of £1.3m towards the development of TenoMiR our promising tendinopathy therapy. The funding will accelerate TenoMiR's development leading to First in Patient clinical trials in 2019. @iiiglasgow UofG MVLS x.com/TendonGlasgow/…

Causeway Therapeutics secures £8.75 million for Phase 2 trial of #tendinopathy therapy University of Glasgow spin-out will use funds to advance development of #microRNA therapeutics. Causeway Therapeutics #tenniselbow longevity.technology/news/causeway-…

We are delighted to launch the new Causeway website! Sign up to learn more about forthcoming announcements and clinical trials for TenoMiR®, a treatment for patients with lateral epicondylitis (tennis elbow). Check it out here: causewaytx.com!

Meet Derek Gilchrist, PhD, Causeway’s Co-founder and Chief Science Officer. He leads the scientific development of TenoMiR®, a therapeutic now in a phase 2 clinical trial for patients with lateral epicondyle tendinopathy (tennis elbow). Learn more here: causewaytx.com

Did you see Causeway’s new website? Check it out and sign up to learn more about forthcoming data announcements and clinical trials for our phase 2 clinical candidate, TenoMiR®, a treatment for patients with lateral epicondylitis (tennis elbow): causewaytx.com

Did you know that each year more than 11 million people in the US experience symptoms of tendinopathy? We are developing treatments to address the molecular cause of tendon disease, not just alleviate symptoms. Visit causewaytx.com to learn more.

Causeway Therapeutics receives a £1m investment to further develop its miRNA29a-based #tendinopathy therapeutic. businessmole.com/causeway-thera…

The basis for any effective therapy is a sound molecular understanding of the disease. It all began with observations made in this paper! x.com/Amro_Hussien/s…

University spin-out raises £1m to develop new tendon injury treatment heraldscotland.com/business_hq/co…

Causeway Therapeutics announces seed investment - myscience.org myscience.org/wire/causeway_… #Medicine #LifeSciences #myscience

BBC News - In pictures: Photographer 'in awe' of older athletes bbc.co.uk/news/uk-englan… Causeway Therapeutics is also in awe!

It's great to see Causeway Therapeutics, University of Glasgow and @iiiglasgow research getting front cover of Molecular Therapy. x.com/TendonGlasgow/…

Causeway Therapeutics is developing therapies based on this research for the treatment of tendinopathy in humans and horses. x.com/CausewayThera/…